Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Greek M.D. Anderson Symptom Inventory: validation and utility in cancer patients.

Mystakidou K, Cleeland C, Tsilika E, Katsouda E, Primikiri A, Parpa E, Vlahos L, Mendoza T.

Oncology. 2004;67(3-4):203-10.

PMID:
15557779
2.

Greek brief pain inventory: validation and utility in cancer pain.

Mystakidou K, Mendoza T, Tsilika E, Befon S, Parpa E, Bellos G, Vlahos L, Cleeland C.

Oncology. 2001;60(1):35-42.

PMID:
11150906
3.

Validation and application of a module of the M. D. Anderson Symptom Inventory for measuring multiple symptoms in patients with gastrointestinal cancer (the MDASI-GI).

Wang XS, Williams LA, Eng C, Mendoza TR, Shah NA, Kirkendoll KJ, Shah PK, Trask PC, Palos GR, Cleeland CS.

Cancer. 2010 Apr 15;116(8):2053-63. doi: 10.1002/cncr.24920.

4.

Cancer-related symptom assessment in Russia: validation and utility of the Russian M. D. Anderson Symptom Inventory.

Ivanova MO, Ionova TI, Kalyadina SA, Uspenskaya OS, Kishtovich AV, Guo H, Mendoza TR, Novik A, Cleeland CS, Wang XS.

J Pain Symptom Manage. 2005 Nov;30(5):443-53.

PMID:
16310618
5.

Validation and application of the Arabic version of the M. D. Anderson symptom inventory in Moroccan patients with cancer.

Nejmi M, Wang XS, Mendoza TR, Gning I, Cleeland CS.

J Pain Symptom Manage. 2010 Jul;40(1):75-86. doi: 10.1016/j.jpainsymman.2009.12.007.

PMID:
20619213
6.

Japanese version of the MD Anderson Symptom Inventory: a validation study.

Okuyama T, Wang XS, Akechi T, Mendoza TR, Hosaka T, Cleeland CS, Uchitomi Y.

J Pain Symptom Manage. 2003 Dec;26(6):1093-104.

PMID:
14654261
7.

Validation of the M.D. Anderson Symptom Inventory Brain Tumor Module (MDASI-BT).

Armstrong TS, Mendoza T, Gning I, Coco C, Cohen MZ, Eriksen L, Hsu MA, Gilbert MR, Cleeland C.

J Neurooncol. 2006 Oct;80(1):27-35. Epub 2006 Apr 6. Erratum in: J Neurooncol. 2006 Oct;80(1):37. Gring, T [corrected to Gning, I].

PMID:
16598415
8.

Filipino version of the M. D. Anderson Symptom Inventory: validation and multisymptom measurement in cancer patients.

Wang XS, Laudico AV, Guo H, Mendoza TR, Matsuda ML, Yosuico VD, Fragante EP, Cleeland CS.

J Pain Symptom Manage. 2006 Jun;31(6):542-52.

PMID:
16793494
9.

Taiwanese version of the M. D. Anderson symptom inventory: symptom assessment in cancer patients.

Lin CC, Chang AP, Cleeland CS, Mendoza TR, Wang XS.

J Pain Symptom Manage. 2007 Feb;33(2):180-8.

PMID:
17280923
10.

Validation study of the Korean version of the M. D. Anderson Symptom Inventory.

Yun YH, Mendoza TR, Kang IO, You CH, Roh JW, Lee CG, Lee WS, Lee KS, Bang SM, Park SM, Cleeland CS, Wang XS.

J Pain Symptom Manage. 2006 Apr;31(4):345-52.

PMID:
16632082
11.

Cancer-related symptom assessment in France: validation of the French M. D. Anderson Symptom Inventory.

Guirimand F, Buyck JF, Lauwers-Allot E, Revnik J, Kerguen T, Aegerter P, Brasseur L, Cleeland CS.

J Pain Symptom Manage. 2010 Apr;39(4):721-33. doi: 10.1016/j.jpainsymman.2009.08.014.

PMID:
20413059
12.

Measuring head and neck cancer symptom burden: the development and validation of the M. D. Anderson symptom inventory, head and neck module.

Rosenthal DI, Mendoza TR, Chambers MS, Asper JA, Gning I, Kies MS, Weber RS, Lewin JS, Garden AS, Ang KK, S Wang X, Cleeland CS.

Head Neck. 2007 Oct;29(10):923-31.

PMID:
17358040
13.

Reliability and validity of the M. D. Anderson Symptom Inventory-Spine Tumor Module.

Armstrong TS, Gning I, Mendoza TR, Vera-Bolanos E, Gilbert MR, Rhines LD, Weinberg JS, Sanchez-Williams G, Levin V, Burton AW, Cleeland C.

J Neurosurg Spine. 2010 Apr;12(4):421-30. doi: 10.3171/2009.10.SPINE0943.

PMID:
20367379
14.

Chinese version of the M. D. Anderson Symptom Inventory: validation and application of symptom measurement in cancer patients.

Wang XS, Wang Y, Guo H, Mendoza TR, Hao XS, Cleeland CS.

Cancer. 2004 Oct 15;101(8):1890-901.

15.

Development and initial validation of the thyroid cancer module of the M. D. Anderson Symptom Inventory.

Gning I, Trask PC, Mendoza TR, Harle MT, Gutierrez KA, Kitaka SA, Sherman SI, Cleeland CS.

Oncology. 2009;76(1):59-68. doi: 10.1159/000178809. Epub 2008 Dec 1.

PMID:
19052478
16.

Validating the M. D. Anderson Symptom Inventory (MDASI) for use in patients with ovarian cancer.

Sailors MH, Bodurka DC, Gning I, Ramondetta LM, Williams LA, Mendoza TR, Agarwal S, Sun CC, Cleeland CS.

Gynecol Oncol. 2013 Aug;130(2):323-8. doi: 10.1016/j.ygyno.2013.05.009. Epub 2013 May 15.

17.

Psychometric testing of the MDASI-HF: a symptom assessment instrument for patients with cancer and concurrent heart failure.

Fadol A, Mendoza T, Gning I, Kernicki J, Symes L, Cleeland CS, Lenihan D.

J Card Fail. 2008 Aug;14(6):497-507. doi: 10.1016/j.cardfail.2008.01.012. Epub 2008 May 27.

PMID:
18672198
18.

Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory.

Cleeland CS, Mendoza TR, Wang XS, Chou C, Harle MT, Morrissey M, Engstrom MC.

Cancer. 2000 Oct 1;89(7):1634-46.

PMID:
11013380
19.

Assessing cancer symptoms in adolescents with cancer using the Taiwanese version of the M. D. Anderson Symptom Inventory.

Tseng TH, Cleeland CS, Wang XS, Lin CC.

Cancer Nurs. 2008 May-Jun;31(3):E9-16. doi: 10.1097/01.NCC.0000305728.50098.51.

PMID:
18453871
20.

Symptom burden of cancer patients: validation of the German M. D. Anderson Symptom Inventory: a cross-sectional multicenter study.

Schmidt H, Cleeland CS, Bauer A, Landenberger M, Jahn P.

J Pain Symptom Manage. 2015 Jan;49(1):117-25. doi: 10.1016/j.jpainsymman.2014.04.007. Epub 2014 May 23.

PMID:
24858739

Supplemental Content

Support Center